Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
This study has been completed.
Study NCT00430196 Information provided by Mount Sinai School of Medicine
First Received: January 30, 2007 Last Updated: January 31, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Upper Limb Spasticity
Additional conditions recognized in this trial
Brain Injuries
Muscle Spasticity
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Disorders of Environmental Origin
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Signs and Symptoms
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
BOTOX®
Zanaflex®
Additional drug interventions recognized in this trial
Botulinum Toxin Type A
Tizanidine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Analgesics
Anticonvulsants
Autonomic Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Neuromuscular Agents
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Mount Sinai School of Medicine
Allergan
Back to top of Main Content
